UBC Antikörper (C-Term)

Produktnummer ABIN2852400

Produktdetails anti-UBC Antikörper

Target: UBC (Ubiquitin C (UBC))

Bindungsspezifität: C-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser UBC Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Spezifität: Reacts with the C-terminus part of human UBC / Ubiquitin C

Aufreinigung: Purified

Immunogen: KLH conjugated synthetic peptide selected from the C-terminal region of human Ubiquitin.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
IHC-P10 μg/mL WB1:100 - 1:500 IF1:10 - 1:50

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.39 mg/mL

Buffer: PBS, Sodium azide 0.09 %

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.

Haltbarkeit: 6 months

Details zu UBC

Target: UBC (Ubiquitin C (UBC))

Andere Bezeichnung: UBC / Ubiquitin C (UBC Produkte)

Hintergrund: UBC protein is a polyubiquitin precursor. Conjugation of ubiquitin monomers or polymers can lead to various effects within a cell, depending on the residues to which ubiquitin is conjugated. Ubiquitination has been associated with protein degradation, DNA repair, cell cycle regulation, kinase modification, endocytosis, and regulation of other cell signaling pathways.

Gen-ID: 7316

Pathways: Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Activation of Innate immune Response, Mitotic G1-G1/S Phases, DNA Replication, Toll-Like Receptors Cascades, Synthesis of DNA, EGFR Downregulation, Ubiquitin Proteasome Pathway